Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant Panitumumab + Chemoradiotherapy in Rectal Cancer
NCT00814619Phase 2Completed
- Sponsor
- Swiss Group for Clinical Cancer Research
- Start
- Nov 2008
- Primary completion
- May 2010
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 2
01
Overview
A Phase 2 trial of panitumumab in rectal cancer, sponsored by Swiss Group for Clinical Cancer Research. Started Nov 2008; status: completed.
02
Drugs
panitumumab
03
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT00814619.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00814619.